U.S. health officials continue pause of Johnson & Johnson vaccine

An expert advisory committee to the Centers for Disease Control and Prevention decided Wednesday it needed more time to consider whether to recommend to resume administering the COVID-19 vaccine made by Johnson & Johnson. The committee's emergency meeting took place less than 36 hours after the CDC and the Food and Drug Administration called for a voluntary pause after receiving reports of serious side effects seen in six women who had received the Johnson & Johnson vaccine.